Weedstock - Cannabis Market Intelligence | Stock Tracker & News

Real-time cannabis stock tracking, expert market analysis, and breaking marijuana industry news.

Home

⭐ Top Story

📈 Top Movers

📰 Today's News

🌿

From the Village Green

Daily curated intelligence from social media — cannabis market trends, breaking news, regulatory updates & M&A signals

From the Village Green

Curated from social media posts and threads


Tilray Reports Strong Q1 2026 Earnings, Cannabis Sector Rallies

Tilray stock surges ~31% after delivering stronger-than-expected Q1 revenue. First revenue beat in over a year signals momentum shift for major cannabis producer and lifts entire sector including CGC and SNDL.

SeekingAlpha


Vireo Growth Closes Q1 with $137.8M Cash, Signals Acquisition Plans

Vireo Growth reports strong Q1 2026 results with $137.8M in cash position. Company signals it expects to remain acquisitive going forward, positioning for strategic M&A in the cannabis space.

GlobeNewswire via MarketWatch


DOJ Reclassifies Cannabis from Schedule I to III—Banking Access Next?

April 23 order moves certain FDA-approved cannabis & medical products to Schedule III. Major win for research & potential banking access. Stocks of Tilray, Canopy, & Curaleaf see double-digit gains on reformhope.

CNBC / DOJ Announcement


Canopy Growth Soars 51% on Rescheduling Rumors, Shows Resilience

Canopy Growth stock jumps 51% on rescheduling optimism. Q2 FY2026 shows Canada adult-use revenue +30%, medical +17%. Despite -65.87% annual decline, regulatory clarity sparks recovery momentum.

aInvest Analysis


Hemp-Derived THC Beverage Sector Faces November 2026 Regulatory Cliff

Industry warns of federal ban on hemp-THC beverages looming November 2026. Companies in unregulated space must pivot; regulated market players may reclaim pricing power as competition consolidates.

aInvest Analysis


Cannabis Stocks on Track for Best Week as FDA Won’t Enforce CBD Rules

FDA signals enforcement pause on certain CBD product regulations. Tilray, Canopy, Curaleaf surge on regulatory relief. Week-long rally fueled by multi-faceted policy tailwinds and reclassification momentum.

Barron’s


iAnthus Reports Fiscal Q1 2026 Financial Results; Consumer Brands in Focus

iAnthus (ITHUF) releases Q1 2026 financials on May 12. Multi-state operator’s results among key reports shaping sentiment. Stock trading at $0.004, down from highs, but fundamentals under review.

GreenStockNews / OTC Markets


CRB Monitor’s 2026 State Transparency Scorecard: 13 Jurisdictions Improve

CRB Monitor releases 2026 transparency scorecard for cannabis regulators. 13 states improve oversight ratings; only 1 declines. Regulatory clarity improving access to financial services for operators.

MJBizDaily


Cannabis Sales Climb 6.5% Sequentially in March; 15-State Analysis

BDSA data shows national cannabis sales grew 6.5% quarter-over-quarter in March. New Cannabis Ventures releases exclusive summary across 15 major markets. Market recovery underway post-regulatory clarity.

NewCannabisVentures / BDSA


Idaho Medical Cannabis Legalization Campaign Exceeds Signature Requirement

Natural Medicine Alliance of Idaho submits 150,000+ signatures (2x requirement) for 2026 ballot measure. Signals continued state-level expansion momentum despite federal restrictions on hemp-THC products.

CannabisBusinessTimes


Cannabis Index Posts Best Week of 2026; Tilray +30%, Canopy +23%

Major cannabis stocks deliver 2026’s strongest weekly gains. Tilray +30%, Canopy +23%, Aurora +13%, SNDL +13%. Sector-wide relief rally driven by reclassification hopes & positive earnings surprises.

BayStreet / MarketBeat


Rescheduling Debate: Can Federal Standards Replace State Pesticide Patchwork?

Cannabis Business Times explores pesticide regulation inconsistency. Rescheduling could enable federal FDA guidance—ending state-by-state compliance burden. Industry awaits clarity on post-Schedule-III enforcement.

CannabisBusinessTimes

Published: Wednesday, May 13, 2026 | 7:00 AM ET | Curated by Sheeba

📅 Yesterday's News & Older Articles →